Our data suggest that ETBF gut colonization elicits a systemic immune response leading to an upsurge of IL27p28 and IL17 cytokines, which, in addition to shaping the lung and liver premetastatic niches, interacts with the myeloid rich tumor microenvironment enhancing the metastatic progression of breast cancer. This evidence concerns the gene IL17A and breast carcinoma.